JPRN-UMIN000006124已完成未知
Efficacy and safety of Doripenem (DRPM) versus Meropenem (MEPM) in patients with febrile neutropenia (FN); Multicenter open-label randomized controlled trial - DRPM versus MEPM in patients with F
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Isolated pathogen not sensitive to DRPM or MEPM. 2) Severe cardiac, hepatic or renal dysfunction. 3) History of allergy or hypersensitivity to beta-lactam antibiotics. 4) History of very severe allergy or hypersensitivity to another drugs or foods. 5) Not evaluable patients for the cause of aging factors 6) Pediatric patients (<16 years). 7) Not eligible patients by the physician.
研究者
相似试验
终止
3 期
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal InfectionsAbscess, Intra-AbdominalAbdomen, AcuteAbdominal PainRuptureInfectionIntestinal PerforationIleusAppendicitisPeritonitisAbdominal AbscessNCT01110382Janssen Research & Development, LLC41
已完成
不适用
Randomized trial of doripenem or meropenem in the treatment of febrile neutropeniapatients with febrile neutropeniaJPRN-UMIN000006944Tokyo Women's Medical University100
已完成
4 期
Examination of the efficacy and safety of Doripenem for hospital-aquired pneumoniaHospital-acquired pneumonia patientJPRN-UMIN000004408Hamamatsu University80
已完成
不适用
Efficacy and safety of doripenem (3g/day) in the treatment of severe/refractory respiratory infectionssevere/refractory respiratory infectionsJPRN-UMIN000012685Department of Respiratory Medicine, University of Occupational and Environmental Health, Japan50
进行中（未招募）
不适用
Meropenem fot the treatment of serious bacterial infections in neonates and young infantssuspected or proven late onset neonatal sepsisMedDRA version: 14.1Level: PTClassification code 10040049Term: Sepsis neonatalSystem Organ Class: 10021881 - Infections and infestationsEUCTR2011-001515-31-LTPENTA Foundation Onlus550